Login

Basil Karampelas discusses ClearVue Technologies Ltd.'s vision and progress in an interview with The Market Herald. 00:10:00

Share On Facebook Share On Twitter

Tommy Logtenberg is the CEO of The Market Herald.

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Private Markets Outlook: Global Trends, India's Potential, and Investment Strategy | Rishi Kapoor, CO-CEO, Investcorp Inc.
00:10:00
Mastering Fund Management: Key Concepts for FRM Candidates | Michael Reeves - Senior Analyst, AnalystPrep
00:10:00
Invest specifically in emerging consumer brands|Kiva Dickinson,Co-Founder and Managing Partner,Selva Ventures
00:10:00
Investing on cryptoassets is he main priority|Bobby Cho,Partner,CMS Holdings
00:10:00
Lessons from Military History: Navigating Success and Failure
00:10:00
"Navigating Business Revival: Insights from Nathan Klitzing | CEO and Principal Wealth Advisor, Cambridge Capital Management, LLC"
00:10:00
Investing Essentials: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants
00:00:00
Sacha Loiseau, Ph.D. Chief Executive Officer, Mauna Kea Technologies
00:10:00
Update from Culpeo Managing Director: Activities & Focus Ahead | Max Tuesley, Managing Director of Culpeo Minerals
00:10:00
We are Wall Street experienced, military trained and client focused|Chance Mims, Founder & CEO,Academy Securities
00:10:00
I'll Burn That Bridge When I Get to It: Essays on Identity Politics and Academic Freedom|Norman Finkelstein,Professor,Xavier University
00:10:00
Marco Claudio Grillo Discusses Abitare In’s Milestones and Future Goals at AIM Investor Day | Marco Claudio Grillo, CEO , Abitare In SpA.

© 2017 - Neuhu+